Glioma extracellular matrix molecules as therapeutic targets

Marzenna Wiranowska, Mumtaz V Rojiani

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Malignant gliomas which rarely metastasize, but are locally highly invasive into theextracellular matrix (ECM) microenvironment in the brain are difficult to treat. Despiteyears of research, current therapies including surgery, radiotherapy and chemotherapy areaimed at debulking of the brain tumor mass and targeting proliferating tumor cells. Thesetherapeutic approaches do not take into consideration the ECM, its composition and thechanges in ECM rigidity which can significantly affect glioma cell motility resulting intumor cell dissemination through the brain and establishment of new, distant tumor foci.Some ECM molecules such as metalloproteinases (MMPs) which are essential in matrixremodeling have been targeted therapeutically.However, due to the highly pleiotropic properties of MMPs, the outcomes of theclinical studies targeting these molecules have been disappointing and often resulted inincreased tumor growth. In addition, current therapies do not address the quiescentpopulation of the cancer stem cells which thrive in the ECM microenvironment of thevascular niche and are protected from therapeutic interventions. This chapter will focuson the review of the most recent information pertaining to the glioma extracellularmicroenvironment and identification of the possible biological targets within ECM foranti-glioma therapy.

Original languageEnglish (US)
Title of host publicationGliomas
Subtitle of host publicationSymptoms, Diagnosis and Treatment Options
PublisherNova Science Publishers, Inc.
Pages263-285
Number of pages23
ISBN (Print)9781626180895
StatePublished - May 1 2013

Fingerprint

Military electronic countermeasures
Glioma
Extracellular Matrix
Molecules
Tumors
Metalloproteases
Brain
Neoplasms
Neoplastic Stem Cells
Therapeutics
Brain Neoplasms
Cell Movement
Chemotherapy
Radiotherapy
Outcome Assessment (Health Care)
Stem cells
Drug Therapy
Rigidity
Surgery
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Wiranowska, M., & Rojiani, M. V. (2013). Glioma extracellular matrix molecules as therapeutic targets. In Gliomas: Symptoms, Diagnosis and Treatment Options (pp. 263-285). Nova Science Publishers, Inc..

Glioma extracellular matrix molecules as therapeutic targets. / Wiranowska, Marzenna; Rojiani, Mumtaz V.

Gliomas: Symptoms, Diagnosis and Treatment Options. Nova Science Publishers, Inc., 2013. p. 263-285.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wiranowska, M & Rojiani, MV 2013, Glioma extracellular matrix molecules as therapeutic targets. in Gliomas: Symptoms, Diagnosis and Treatment Options. Nova Science Publishers, Inc., pp. 263-285.
Wiranowska M, Rojiani MV. Glioma extracellular matrix molecules as therapeutic targets. In Gliomas: Symptoms, Diagnosis and Treatment Options. Nova Science Publishers, Inc. 2013. p. 263-285
Wiranowska, Marzenna ; Rojiani, Mumtaz V. / Glioma extracellular matrix molecules as therapeutic targets. Gliomas: Symptoms, Diagnosis and Treatment Options. Nova Science Publishers, Inc., 2013. pp. 263-285
@inbook{fb2ba45f23fd44f38b11a4fda402dad2,
title = "Glioma extracellular matrix molecules as therapeutic targets",
abstract = "Malignant gliomas which rarely metastasize, but are locally highly invasive into theextracellular matrix (ECM) microenvironment in the brain are difficult to treat. Despiteyears of research, current therapies including surgery, radiotherapy and chemotherapy areaimed at debulking of the brain tumor mass and targeting proliferating tumor cells. Thesetherapeutic approaches do not take into consideration the ECM, its composition and thechanges in ECM rigidity which can significantly affect glioma cell motility resulting intumor cell dissemination through the brain and establishment of new, distant tumor foci.Some ECM molecules such as metalloproteinases (MMPs) which are essential in matrixremodeling have been targeted therapeutically.However, due to the highly pleiotropic properties of MMPs, the outcomes of theclinical studies targeting these molecules have been disappointing and often resulted inincreased tumor growth. In addition, current therapies do not address the quiescentpopulation of the cancer stem cells which thrive in the ECM microenvironment of thevascular niche and are protected from therapeutic interventions. This chapter will focuson the review of the most recent information pertaining to the glioma extracellularmicroenvironment and identification of the possible biological targets within ECM foranti-glioma therapy.",
author = "Marzenna Wiranowska and Rojiani, {Mumtaz V}",
year = "2013",
month = "5",
day = "1",
language = "English (US)",
isbn = "9781626180895",
pages = "263--285",
booktitle = "Gliomas",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Glioma extracellular matrix molecules as therapeutic targets

AU - Wiranowska, Marzenna

AU - Rojiani, Mumtaz V

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Malignant gliomas which rarely metastasize, but are locally highly invasive into theextracellular matrix (ECM) microenvironment in the brain are difficult to treat. Despiteyears of research, current therapies including surgery, radiotherapy and chemotherapy areaimed at debulking of the brain tumor mass and targeting proliferating tumor cells. Thesetherapeutic approaches do not take into consideration the ECM, its composition and thechanges in ECM rigidity which can significantly affect glioma cell motility resulting intumor cell dissemination through the brain and establishment of new, distant tumor foci.Some ECM molecules such as metalloproteinases (MMPs) which are essential in matrixremodeling have been targeted therapeutically.However, due to the highly pleiotropic properties of MMPs, the outcomes of theclinical studies targeting these molecules have been disappointing and often resulted inincreased tumor growth. In addition, current therapies do not address the quiescentpopulation of the cancer stem cells which thrive in the ECM microenvironment of thevascular niche and are protected from therapeutic interventions. This chapter will focuson the review of the most recent information pertaining to the glioma extracellularmicroenvironment and identification of the possible biological targets within ECM foranti-glioma therapy.

AB - Malignant gliomas which rarely metastasize, but are locally highly invasive into theextracellular matrix (ECM) microenvironment in the brain are difficult to treat. Despiteyears of research, current therapies including surgery, radiotherapy and chemotherapy areaimed at debulking of the brain tumor mass and targeting proliferating tumor cells. Thesetherapeutic approaches do not take into consideration the ECM, its composition and thechanges in ECM rigidity which can significantly affect glioma cell motility resulting intumor cell dissemination through the brain and establishment of new, distant tumor foci.Some ECM molecules such as metalloproteinases (MMPs) which are essential in matrixremodeling have been targeted therapeutically.However, due to the highly pleiotropic properties of MMPs, the outcomes of theclinical studies targeting these molecules have been disappointing and often resulted inincreased tumor growth. In addition, current therapies do not address the quiescentpopulation of the cancer stem cells which thrive in the ECM microenvironment of thevascular niche and are protected from therapeutic interventions. This chapter will focuson the review of the most recent information pertaining to the glioma extracellularmicroenvironment and identification of the possible biological targets within ECM foranti-glioma therapy.

UR - http://www.scopus.com/inward/record.url?scp=84892914723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892914723&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84892914723

SN - 9781626180895

SP - 263

EP - 285

BT - Gliomas

PB - Nova Science Publishers, Inc.

ER -